STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)–STAT3 pathway

Amy Belton; Lingling Xian; Tait Huso; Michael Koo; Li Z. Luo; James Turkson; Brent D.G. Page; Patrick T. Gunning; Guosheng Liu; David L. Huso; Linda M.S. Resar

doi:10.3109/10428194.2016.1153089

STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)–STAT3 pathway

Amy Belton, Lingling Xian, Tait Huso, Michael Koo, Li Z. Luo, James Turkson, Brent D.G. Page, Patrick T. Gunning, Guosheng Liu, David L. Huso, Linda M.S. Resar

School of Medicine

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	2681-2684
Number of pages	4
Journal	Leukemia and Lymphoma
Volume	57
Issue number	11
DOIs	https://doi.org/10.3109/10428194.2016.1153089
State	Published - Nov 1 2016

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.3109/10428194.2016.1153089

Cite this

Belton, A., Xian, L., Huso, T., Koo, M., Luo, L. Z., Turkson, J., Page, B. D. G., Gunning, P. T., Liu, G., Huso, D. L., & Resar, L. M. S. (2016). STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)–STAT3 pathway. Leukemia and Lymphoma, 57(11), 2681-2684. https://doi.org/10.3109/10428194.2016.1153089

Belton, A, Xian, L, Huso, T, Koo, M, Luo, LZ, Turkson, J, Page, BDG, Gunning, PT, Liu, G, Huso, DL & Resar, LMS 2016, 'STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)–STAT3 pathway', Leukemia and Lymphoma, vol. 57, no. 11, pp. 2681-2684. https://doi.org/10.3109/10428194.2016.1153089

@article{9ed3dfc5cf314aea92aeb03928efc629,

title = "STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)–STAT3 pathway",

author = "Amy Belton and Lingling Xian and Tait Huso and Michael Koo and Luo, {Li Z.} and James Turkson and Page, {Brent D.G.} and Gunning, {Patrick T.} and Guosheng Liu and Huso, {David L.} and Resar, {Linda M.S.}",

year = "2016",

month = nov,

day = "1",

doi = "10.3109/10428194.2016.1153089",

language = "English (US)",

volume = "57",

pages = "2681--2684",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "11",

}

TY - JOUR

T1 - STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)–STAT3 pathway

AU - Belton, Amy

AU - Xian, Lingling

AU - Huso, Tait

AU - Koo, Michael

AU - Luo, Li Z.

AU - Turkson, James

AU - Page, Brent D.G.

AU - Gunning, Patrick T.

AU - Liu, Guosheng

AU - Huso, David L.

AU - Resar, Linda M.S.

PY - 2016/11/1

Y1 - 2016/11/1

UR - http://www.scopus.com/inward/record.url?scp=84961200262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961200262&partnerID=8YFLogxK

U2 - 10.3109/10428194.2016.1153089

DO - 10.3109/10428194.2016.1153089

M3 - Letter

C2 - 26952843

AN - SCOPUS:84961200262

SN - 1042-8194

VL - 57

SP - 2681

EP - 2684

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 11

ER -

STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)–STAT3 pathway

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this